Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 22,127,000 | 26,107,000 | 30,390,000 | 32,639,000 | 24,890,000 |
| Cost of Goods | 4,853,000 | 4,371,000 | 4,261,000 | 4,006,000 | 3,788,000 |
| Gross Profit | 17,274,000 | 21,736,000 | 26,129,000 | 28,633,000 | 21,102,000 |
| Operating Expenses | 9,074,000 | 7,612,000 | 8,496,000 | 6,440,000 | 5,837,000 |
| Operating Income | 8,200,000 | 14,124,000 | 17,633,000 | 22,193,000 | 15,265,000 |
| Interest Expense | 1,077,000 | 1,118,000 | 964,000 | 688,000 | 412,000 |
| Other Income | 676,000 | 523,000 | 428,000 | 154,000 | 3,000 |
| Pre-tax Income | 7,799,000 | 13,529,000 | 17,097,000 | 21,659,000 | 14,856,000 |
| Income Tax | 2,339,000 | 8,885,000 | 3,609,000 | 3,553,000 | 2,797,000 |
| Net Income Continuous | 5,460,000 | 4,644,000 | 13,488,000 | 18,106,000 | 12,059,000 |
| Minority Interests | 5,000 | 16,000 | -13,000 | -2,000 | -42,000 |
| Net Income | $5,455,000 | $4,628,000 | $13,501,000 | $18,108,000 | $12,101,000 |
| EPS Basic Total Ops | 4.20 | 3.54 | 10.08 | 12.37 | 7.95 |
| EPS Basic Continuous Ops | 4.21 | 3.55 | 10.07 | 12.37 | 7.92 |
| EPS Diluted Total Ops | 4.17 | 3.51 | 9.94 | 11.91 | 7.35 |
| EPS Diluted Continuous Ops | 4.17 | 3.52 | 9.93 | 11.90 | 7.32 |
| EPS Diluted Before Non-Recurring Items | 6.15 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $9,629,000 | $15,410,000 | $18,791,000 | $23,291,000 | $16,315,000 |